Product Inquiry
Asset Licensing Opportunity
Resources
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Restoret | EYE103; EYE-103; MK-3000; ANT-39 | Phase 3 Clinical | Diabetic macular oedema; Macular Degeneration | Details |
Customer Reviews